To assess the validity of model predicted changes to ERK and AKT pathway inputs, we used a previous molecular study of EMT-dependent signaling across multiple in vitro EMT models and more than 70 lung cancer cell lines (Salt et al., 2014). The gene discussed is AKT1; the disease is lung cancer.